CombiGene AB (publ) (STO:COMBI)
Sweden
· Delayed Price · Currency is SEK 2.410
0.00 (0.00%)
Jun 23, 2025, 4:46 PM CET
CombiGene AB Revenue
In the year 2024, CombiGene AB had annual revenue of 2.00M SEK, down -71.47%. CombiGene AB had revenue of 326.19K in the quarter ending December 31, 2024, a decrease of -77.84%.
Revenue
2.00M
Revenue Growth
-71.47%
P/S Ratio
23.87
Revenue / Employee
222.13K
Employees
9
Market Cap
47.72M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.00M | -5.01M | -71.47% |
| Dec 31, 2023 | 7.01M | -21.72M | -75.61% |
| Dec 31, 2022 | 28.73M | -62.42M | -68.48% |
| Dec 31, 2021 | 91.15M | 80.32M | 741.81% |
| Dec 31, 2020 | 10.83M | -4.16M | -27.75% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.24B |
| Sectra AB | 3.31B |
| Getinge AB | 35.57B |
| Asker Healthcare Group AB | 15.57B |
| Medicover AB | 23.56B |
| Camurus AB | 2.04B |
| AddLife AB | 10.42B |
| Vimian Group AB | 4.24B |